title: Effective treatment with cyclosporin A in amegacaryocytic purpura followed by ischemic complications.
authors.forename: P
authors.initials: P
authors.lastname: Musto
authors.forename: N
authors.initials: N
authors.lastname: Cascavilla
authors.forename: N
authors.initials: N
authors.lastname: Di Renzo
authors.forename: S
authors.initials: S
authors.lastname: Ladogana
authors.forename: A
authors.initials: A
authors.lastname: La Sala
authors.forename: L
authors.initials: L
authors.lastname: Melillo
authors.forename: M
authors.initials: M
authors.lastname: Nobile
authors.forename: M
authors.initials: M
authors.lastname: Carotenuto
mesh_terms: D000368:Aged; D001161:Arteriosclerosis / Q000150:complications; D001327:Autoimmune Diseases / Q000150:complications / Q000188:drug therapy*; D002545:Brain Ischemia / Q000209:etiology*; D003524:Cyclosporins / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008533:Megakaryocytes / Q000473:pathology; D009203:Myocardial Infarction / Q000209:etiology*; D010976:Platelet Count / Q000187:drug effects; D011696:Purpura, Thrombocytopenic / Q000150:complications / Q000188:drug therapy* / Q000473:pathology
chemical_list: D003524:Cyclosporins